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Abstract We have obtained a novel cDNA species of MKK3, 
termed MKK3b. MKK3b cDNA differs from its original form, 
MKK3, at the 5'-end, encoding 29 extra amino acids in the N-
terminus. Analysis of MKK3 genomic DNA structure revealed 
that the MKK3b-unique 5'-end sequence is derived from an exon 
different from that of MKK3, and that they share identical 
sequences thereafter. This suggests that the two cDNA forms of 
MKK3 are either generated by differential splicing of the same 
gene or derived from differential promoter utilization. Northern 
blotting analysis showed that MKK3b mRNA is much more 
abundant than MKK3. Functional characterization based on the 
activation of p38 revealed that MKK3b is more efficient than 
MKK3 in mediating downstream signalling events. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Numerous extracellular signals are transduced through a 
cascade of phosphorylation, to the activation of the mito-
gen-activated protein kinases (MAPK) . Different groups of 
M A P kinases are activated by distinct subsets of M A P kinase 
kinases. For example, Mekl /2 , Sekl (also known as M K K 4 or 
JNKK1) , and MKK3/6 are believed to directly activate Erks, 
SAPKs (or JNKs) , and p38 (or M P K 2 , R K , and CSBP), 
respectively (reviewed in [1-10]). A c D N A encoding one of 
the M K K s , M K K 3 , has been cloned and shown to be present 
in all tissues and enriched in skeletal muscle [9]. M K K 3 ap-
pears to specifically activate p38 M A P kinase, mediating 
stress-induced responses [11-13]. 
We initially observed that in THP-1 and HeLa cells the 
major protein band detected by Western blotting using anti-
M K K 3 antibodies raised against either a C-terminal peptide 
of M K K 3 or recombinant M K K 3 protein was approximately 
47 k D a in size, indicating a discrepancy between the molec-
ular weight deduced from the open reading frame of the iden-
tified M K K 3 c D N A [9] and the apparent molecular weight of 
the natural M K K 3 protein. This suggested that there might be 
more than one c D N A species for M K K 3 . We therefore 
screened a human c D N A library using the M K K 3 c D N A as 
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a probe. As a result, we obtained a novel species of M K K 3 
m R N A , referred to as M K K 3 b , which differs from the ini-
tially characterized M K K 3 at the amino terminus. We have 
determined the multiple-exon/intron structure in the 5'-end 
region of the M K K 3 gene, where the novel M K K 3 m R N A 
is derived. Based on Nor thern blotting analysis, M K K 3 b is 
the predominant isoform in all tissues. Furthermore, we show 
that M K K 3 b is more efficient in mediating its downstream 
events than M K K 3 . 
2. Materials and methods 
2.1. Identification of a novel form of human MKK3 cDNA 
A human B lymphoma (Daudi) cDNA library in the pCDNAII 
vector (Invitrogen) was screened using 32P-labelled MKK3 cDNA as 
a probe. The isolated plasmid DNA was sequenced using the dideoxy-
nucleotide termination sequencing kit (Amersham). One of the iso-
lated clones that appears to contain the complete coding sequence of 
MKK3 was subcloned into the mammalian expression vector 
pCDNA3. A PCR-based procedure was adopted to create a double 
mutant of MKK3b, MKK3b(E), by replacing the phosphorylation 
sites Ser218 and Thr222 with Glu as previously described [14]. 
2.2. Isolation of human genomic DNA of MKK3 
A human placenta genomic DNA library in the VFixII vector 
(Stratagene) was screened with the MKK3 cDNA as a probe. Ge-
nomic DNA inserts were fragmented by digestion with EcoRl and 
subcloned into pBluescript for further analysis. 
2.3. Northern hybridization analysis of MKK3b and MKK3 
The 5'-end region that is unique to MKK3b was PCR-amplified. 
The MKK3b DNA fragment was 32P-labelled by a random priming 
kit (Boehringer Mannheim), and was used to probe a multiple tissue 
RNA blot (Clontech). An MKK3-specific probe was prepared using 
two oligonucleotide primers, derived from the region unique to the 
original MKK3 cDNA, that partially anneal to each other to enable 
DNA elongation by Klenow DNA polymerase, generating a synthetic 
DNA probe of approximately 100 nucleotides in length with a specific 
activity of 2 X 109 cpm/ug. 
2.4. Transient co-expression of p38 with MKK3 and MKK3b in COS-7 
cells and immunokinase assays 
Full-length cDNAs of flag-tagged p38, MKK3, and MKK3b were 
constructed into the mammalian expression vector pCDNA3 as pre-
viously described [14]. COS-7 cells were co-transfected of pCDNA3-
p38 with either pCDNA3-MKK3 or MKK3b using lipofectamine 
according to the manufacturer's instructions. Transfection efficiency 
was evaluated by co-transfection with the plasmid pCMWß-galacto-
sidase (Clontech). After 48 h of transfection, transiently expressed p38 
was immunoprecipitated by the anti-flag monoclonal antibody M2 
(Kodak-IBI). Immunokinase assays were performed using the immu-
noprecipitates and recombinant GST-ATF2-(1-109) as a substrate as 
described [14]. 
2.5. Reporter gene expression 
The GAL4-responsive reporter plasmid, pG5ElbLuc, contains five 
GAL4 binding sites upstream of a minimal promoter and luciferase 
gene. pG5ElbLuc was co-transfected into CHO cells with a construct 
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expressing the GAL4 binding domain fused to ATF2-(l-505) [14,15]. 
Activation of an ATF-2 reporter gene by MKK3 or MKK3b was 
examined by co-transfection of the reporter plasmid separately with 
each of the expression plasmids as indicated in the text. 
3. Results 
3.1. Cloning of a novel MKK3 RNA species 
To initially screen for a possible isoform of MKK3, its full-
length cDNA fragment was 32P-labelled and used to screen a 
human cDNA library. Sequencing analysis of cDNA inserts 
revealed a novel form of MKK3, which differs from the one 
previously characterized at the 5'-end coding sequence as well 
as the 5'-untranslated region (Fig. 1). The novel cDNA en-
codes 351 amino acids, 29 residues longer than MKK3 (Fig. 
1A). The two MKK3 RNA species have identical downstream 
sequences. An in-frame stop codon (TAG) 36 nt upstream of 
the putative translation start site indicates that the cDNA is 
of full length (Fig. IB). Recombinant MKK3b expressed in 
COS-7 cells has an apparent molecular weight close to 47 
kDa, consistent with the estimated molecular weight for the 
natural protein detected by Western blotting (data not 
shown). 
3.2. The gene structure of MKK3 
In order to understand the origin of the novel MKK3 
mRNA species, we used the cDNA fragment unique to the 
A. 
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Fig. 1. The primary sequence and genomic structure of MKK3b. A: 
The previously identified MKK3 is compared to the novel MKK3b, 
showing that MKK3b is 29 amino acid residues longer than MKK3 
at the N-terminus. B: The exon-intron structure of MKK3b ge-
nomic DNA. The nucleotide sequences in capital letters are exon se-
quences; numbers refer to the positions of the nucleotide sequence 
of MKK3b cDNA. The MKK3b-unique nucleotide sequence is de-
rived from a single exon, exon 1 (1-95). Exon 1 contains the trans-
lation initiation codon (squared), as well as an in-frame stop codon 
(squared) upstream of the initiation codon. Partial intron sequences 
are shown in lower-case letters; and splicing consensus sites, GT 
and AG respectively for the left site and right site, are marked by 
black dots. The cDNA sequence of human MKK3b has been de-
posited in the GenBank data base with accession number U66839. 
C: A diagram showing MKK3 and MKK3b diverge exactly before 
the intron/exon junction of the putative exon 2. Exon la is a hypo-
thetical denotation for the divergent 5'-end sequence of MKK3; 
exon lb refers to the 5'-end exon of MKK3b. The relative locations 
of the translation initiation codon for each mRNA are indicated. 
Fig. 2. Tissue distribution of MKK3b. The DNA sequence unique 
to MKK3b, exon 1, was radioactively labelled and utilized to probe 
a Northern blot containing different human tissue RNAs as indi-
cated at the top. The arrow points to the single hybridized mRNA 
species of 2.6 kb in size. A ß-actin probe (from Clontech) was used 
to probe the same blot for RNA loading (lower panel). 
b-form MKK3 cDNA as a probe to screen a human placenta 
genomic DNA library. Seven clones were isolated and sub-
cloned into pBluescript. The genomic DNA inserts were di-
gested with various restriction enzymes and subjected to 
Southern analysis using the same DNA probe. As a result, a 
5 kb EcoRl fragment hybridized to the b-unique probe and 
subsequently subcloned for sequencing analysis. As shown in 
Fig. IB, the MKK3b-unique 5'-end sequence is derived from 
a single exon, and contains the translation initiation codon. 
This exon is linked to a second exon that is shared by the 
original MKK3 cDNA. As indicated in Fig. IB, translation of 
MKK3 starts in the second exon. 
3.3. MKK3b is a predominant form of MKK3 
We next analyzed the tissue distribution of the novel 
MKK3 mRNA species by hybridizing the b-unique DNA 
fragment as a probe to a Northern blot containing eight tissue 
RNA samples. Results showed that the RNA distribution is 
similar to that with the full-length DNA probe (Fig. 2). When 
we used a probe specific for the original MKK3 cDNA to 
hybridize the same blot, no hybridization signal was detected 
(data not shown). This is consistent with our observation that 
anti-MKK3 antibodies only reveal a 47 kDa protein in West-
ern blotting (data not shown). Collectively, these data indicate 
that MKK3b is the major variant of the MKK3 gene. 
3.4. MKK3b is more active in the activation of p38 
In order to compare the kinase activity of the two MKK3 
products, the flag-tagged p38 was co-transfected into COS-7 
cells with either MKK3 or MKK3b. Cells were lysed after 48 
h, and subjected to immunoprecipitation with the M-2 anti-
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flag antibody. The purified p38 was assayed for its activity 
using ATF2 as a substrate. As shown in Fig. 3, MKK3b is 
capable of activating p38 kinase activity. In addition, it is 
evident that MKK3b is more active than MKK3. We and 
others have previously shown that p38 can phosphorylate 
the transcription factor ATF2 and increases ATF2-dependent 
reporter gene expression [11,14,15]. We next carried out co-
transfection of the reporter gene in different combinations 
with p38, constitutively active mutants of MKK3 or 
MKK3b, MKK3(E) or MKK3b(E), respectively. Results 
showed that MKK3(E) alone does not activate the reporter. 
When co-transfected with p38, MKK3(E) activates the report-
er approximately 2-fold. In contrast, MKK3b(E) exhibited 
much higher efficiency in activating the endogenous p38, 
and by itself resulted in a 7-fold increase in the reporter tran-
scription activity. In the presence of co-transfected p38, a 
higher stimulation by the MKK3b(E) was observed (9-fold). 
These results confirm the effect of MKK3(E) on the ATF2 
reporter gene expression previously reported by ourselves and 
others [14,15], and show that the constitutive form of the 
newly identified MKK3 (MKK3b(E)) is much more efficient 
in activating the ATF2 transcriptional activity (Fig. 4). 
4. Discussion 
We have obtained a novel cDNA species of the human 
MKK3 gene, which encodes a new MKK3 protein of 351 
amino acids in length, 29 amino acid residues longer than 
the MKK3 previously identified [9]. The nature of the origin 
of the two MKK3 mRNA species is unclear. They may either 
be a product of differential splicing or are derived from differ-
ential promoter utilization. We favor the second possibility 
because they diverge completely in their 5'-ends, and because 
we failed, by 5'-end extension experiments, to obtain any 
further upstream sequences that may be identical to both 
the mRNAs. Therefore, the transcription initiation site may 
be different between the two transcripts. 
Northern blotting analysis revealed that the distribution 
pattern of the novel mRNA species almost entirely mirrors 
that using the full-length MKK3 DNA as a probe, being most 
abundant in skeletal muscle and nearly undetectable in brain. 
The new probe hybridized to a mRNA of the same molecular 
weight, approximately 2.6 kb in length. Furthermore, the 
probe unique to the previously identified MKK3 failed to 
detect any mRNA on the same Northern blot. Based on the 
analysis of the MKK3 genomic DNA, it was found that the 
5'-untranslated sequence of the previously identified MKK3 is 
Fig. 3. Activation of p38 by MKK3 and MKK3b. COS-7 cells were 
co-transfected with the flag-tagged p38 together with pCDNA3 con-
structs expressing MKK3, MKK3b, or the empty vector as a con-
trol. The kinase activity of p38 isolated by immunoprecipitation was 
measured with GST-ATF2(1-109) as substrate. Similar results were 
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Fig. 4. Stimulation of ATF2-dependent gene expression by MKK3 
and MKK3b. An ATF2-dependent reporter gene was co-transfected 
into CHO cells with ß-galactosidase expression vector pCMV-ß-gal 
and a different combination with p38, the constitutive form of 
MKK3 (MKK3(E)) or MKK3b (MKK3b(E)). Empty vector 
pCDNA3 was used to normalize the total DNA to 1 ug per trans-
fection. The ratio of luciferase activity to ß-galactosidase activity is 
presented as the mean ± S.D. (n = 3). 
linked, but not contiguous, to the new MKK3b sequence. 
Together with the fact that the two cDNA species diverge 
exactly at the intron-exon junction, it is unlikely that the 
original sequence is a cloning artefact. It is of interest to 
extend the analysis of the MKK3 tissue distribution, as it is 
possible that MKK3 may be present in as yet unidentified cell 
types. 
Although MKK3b has a much stronger effect on p38 acti-
vation than MKK3, it is possible that MKK3 may display a 
stronger kinase activity in the phosphorylation of other sub-
strates. The N-terminal sequence difference of MKK3 and 
MKK3b may allow differential subcellular localization of 
the proteins. Indeed, there is a cluster of positively charged 
amino acid residues (Arg/Lys residues) in the unique N-termi-
nus of MKK3b, which is identical to a putative nuclear local-
ization site [16]. Whether this sequence has any role in the 
physiological function of MKK3b still awaits further investi-
gation. Understanding the functional difference between the 
two forms of MKK3 would provide more insight into the 
mechanism by which the p38 MAP kinase cascade operates. 
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